C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 31/14 (2006.01)
Patent
CA 2487211
The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.
L'invention concerne l'inhibition de la réplication du virus de l'hépatite C (HCV). En particulier, des modes de réalisation de l'invention concernent des composés et des procédés permettant d'inhiber une activité enzymatique d'une ARN polymérase ARN-dépendante du HCV. L'invention concerne également des compositions et des procédés pour la prophylaxie et pour le traitement de l'infection du HCV.
Curran Patrick J.
Deng Yongqi
Popovici-Muller Janeta
Rosner Kristin E.
Shipps Gerald W. Jr.
Neogenesis Pharmaceuticals Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Pyrazolo(1,5a) pyrimidine compounds as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo(1,5a) pyrimidine compounds as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo(1,5a) pyrimidine compounds as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1659644